Middle East and Africa Blood Screening Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Middle East and Africa Blood Screening Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025


  • Products Id :- DBMR744
  • |
  • Pages: 100
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Market Definition

Blood is an essential requirement for health care which helps in the proper functioning of the human body. A blood screening is defined as a medical process for the detection of disease. The process of blood screening is carried out for a variety of reasons in which the most common reason is pregnancy, human immunodeficiency (HIV) and blood type screenings. Screening of the blood may also be done to detect conditions such as general infections and cancer. Different types of assays are performed in detecting health related problems. Collected blood is screened with different techniques such as ELISA, NAT technology, next generation sequencing and many others. EIAs, particle agglutination (rapid tests) and (Chemiluminescence Immunoassays) CLIAs assays are used for blood screening. Most (Chemiluminescence Immunoassays) CLIAs consists greater specificity and sensitivity as compare to rapid tests that provides better result in screening process.

Middle East & Africa blood screening market is expected to reach with healthy CAGR of 8.7% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Market Segmentation

By Products & Services (Reagents & Kits, Instruments, Software & Services), Technology (Enzyme-Linked Immunosorbent Assay, Rapid Tests, Next-Generation Sequencing, Nucleic Acid Test, Western Blot Assay, Others), Disease Type (Oncology, Diabetes Mellitus, Cold & Flu, Cholesterol, Infectious Diseases, Respiratory Diseases, HIV/AIDS, Others), End User (Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)

Major growing sectors under the market segmentation are as follows:

In products & services, reagents are dominating this market as reagents are majorly used in laboratory, company and other places to perform experiment and also to find or detect the diseases related to human health.

In technology, enzyme-linked immunosorbent assay (ELISA) is dominating this market as it is more used with accurate result and less costly in the market. It is a versatile tool for physicians, laboratories, and medical professionals all over the world.

In disease type, oncology is dominating this market as increasing population is detecting more with cancer cases due to exposure to UV lights in today's world. The Blood screening method is found to be more useful for detecting cancer.

In end user, diagnostic centers is dominating this market as people mostly prefer diagnostics centers and doctors also suggest patients to visit diagnostics center for detection of diseases.

The key market players for Middle East & Africa blood screening market are listed below:

Enzo Biochem Inc.

Meridian Bioscience, Inc.

Bio-Rad Laboratories, Inc.

Thermo Fisher Scientific Inc.

BD

bioMerieux SA

Beckman Coulter, Inc.

Abbott

F. Hoffmann-La Roche Ltd

Cepheid

Grifols

Seimens AG

Ortho Clinical Diagnostics

Immucor, Inc.

Hologic Inc.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

TABLE OF CONTENTS

1 INTRODUCTION 29

1.1 OBJECTIVES OF THE STUDY 29

1.2 MARKET DEFINITION 29

1.3 OVERVIEW OF MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET 29

1.4 CURRENCY AND PRICING 30

1.5 LIMITATION 31

1.6 MARKETS COVERED 31

2 MARKET SEGMENTATION 35

2.1 MARKETS COVERED 35

2.2 GEOGRAPHIC SCOPE 36

2.3 YEARS CONSIDERED FOR THE STUDY 37

2.4 CURRENCY AND PRICING 37

2.5 RESEARCH METHODOLOGY 38

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 41

2.7 DBMR MARKET POSITION GRID 42

2.8 THE CATEGORY VS TIME GRID 43

2.9 THE CATEGORY VS TIME GRID 44

2.10 DBMR MARKET CHALLENGE MATRIX 45

2.11 SECONDARY SOURCES 46

2.12 ASSUMPTIONS 46

3 MARKET OVERVIEW 47

3.1 DRIVERS 49

3.1.1 RISE IN THE DEMAND OF BLOOD DONATIONS AND BLOOD DONORS 49

3.1.2 RISING PREVALENCE IN NUMBER OF DISEASES 49

3.1.3 RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS 50

3.2 RESTRAINTS 51

3.2.1 LACK OF USING NAT TECHNLOGY IN EMERGING COUNTRIES 51

3.2.2 HIGH COST OF TECHNOLOGY AND INSTRUMENTS 51

3.2.3 EMERGING ALTERNATIVE TECHNOLOGIES 52

3.3 OPPORTUNITIES 53

3.3.1 INCREASING MICROBIOLOGY SCREENING & MULTIPLEXING 53

3.4 CHALLENGES 54

3.4.1 REDUCTION IN PRICE FOR TECHNOLOGY AND INSTRUMENT 54

4 EXECUTIVE SUMMARY 55

5 PREMIUM INSIGHTS 58

6 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES 60

6.1 OVERVIEW 61

6.2 REAGENTS & KITS 63

6.2.1 ELISA REAGENTS & KITS 65

6.2.1.1 IMMUNOSORBENTS 66

6.2.1.2 CONJUGATES 66

6.2.1.3 SUBSTRATES 66

6.2.1.4 CONTROLS 66

6.2.1.5 SAMPLE DILUENTS AND WASH SOLUTIONS 66

6.2.2 NAT REAGENTS & KITS 66

6.2.2.1 PROBES AND PRIMERS 67

6.2.2.2 ENZYMES AND POLYMERASES 67

6.2.2.3 LABELING AND DETECTION REAGENTS 67

6.2.2.4 STANDARDS AND CONTROLS 67

6.2.2.5 BUFFERS, NUCLEOTIDES AND SOLUTIONS 67

6.3 INSTRUMENTS 68

6.3.1.1 INSTRUMENTS, PRODUCT TYPE 69

6.3.1.1.1 SEMI AUTOMATED 69

6.3.1.1.2 AUTOMATED 69

6.3.1.2 INSTRUMENTS, PURCHASE TYPE 69

6.3.1.2.1 OUTRIGHT PURCHASE 69

6.3.1.2.2 RENTAL 69

6.4 SOFTWARE & SERVICES 70

7 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY TECHNOLOGY 71

7.1 OVERVIEW 72

7.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) 74

7.2.1 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY PLATFORM 76

7.2.1.1 COLORIMETRIC IMMUNOASSAY (CI) 76

7.2.1.2 CHEMILUMINESCENCE IMMUNOASSAY (CLIA) 76

7.2.1.3 FLUORESCENCE IMMUNOASSAY (FIA) 76

7.2.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY GENERATIONS 76

7.2.2.1 FIRST-GENERATION ELISA 76

7.2.2.2 SECOND-GENERATION ELISA 76

7.2.2.3 THIRD-GENERATION ELISA 76

7.2.2.4 FOURTH-GENERATION ELISA 76

7.3 RAPID TESTS 77

7.4 NEXT-GENERATION SEQUENCING (NGS) 78

7.5 NUCLEIC ACID TEST 79

7.5.1 REAL-TIME POLYMERASE CHAIN REACTION (PCR) 80

7.5.2 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) 80

7.6 WESTERN BLOT ASSAY 81

7.7 OTHERS 82

8 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY DISEASE TYPE 83

8.1 OVERVIEW 84

8.2 ONCOLOGY 86

8.3 DIABETES MELLITUS 87

8.4 COLD & FLU 88

8.5 CHOLESTEROL 89

8.6 INFECTIOUS DISEASES 90

8.7 RESPIRATORY DISEASES 91

8.8 HIV/AIDS 92

8.9 OTHERS 93

9 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY END USER 94

9.1 OVERVIEW 95

9.2 DIAGNOSTIC CENTERS 97

9.3 BLOOD BANK 98

9.4 HOSPITALS 99

9.5 CLINICS 100

9.6 AMBULATORY SURGICAL CENTERS 101

10 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY GEOGRAPHY 102

10.1 MIDDLE EAST & AFRICA 102

10.1.1 SOUTH AFRICA 112

1.1.1 EGYPT

1.1.2 SAUDI ARABIA

1.1.3 UNITED ARAB EMIRATES

1.1.4 ISRAEL

10.1.2 REST OF MIDDLE EAST & AFRICA 119

11 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, COMPANY LANDSCAPE 120

11.1 COMPANY SHARE ANALYSIS: MIDDLE EAST-AND AFRICA 120

12 COMPANY PROFILES 121

12.1 F. HOFFMANN-LA ROCHE LTD 121

12.1.1 COMPANY OVERVIEW 121

12.1.2 REVENUEANALYSIS 121

12.1.3 COMPANY SHARE ANALYSIS 122

12.1.4 PRODUCT PORTFOLIO 122

12.1.5 RECENT DEVELOPMENT 123

12.2 ABBOTT 124

12.2.1 COMPANY OVERVIEW 124

12.2.2 REVENUE ANALYSIS 124

12.2.3 COMPANY SHAREV ANALYSIS 125

12.2.4 PRODUCT PORTFOLIO 125

12.2.5 RECENT DEVELOPMENT 126

12.3 THERMO FISHER SCIENTIFIC INC. 127

12.3.1 COMPANY OVERVIEW 127

12.3.2 REVENUE ANALYSIS 127

12.3.3 COMPANY SHAREV ANALYSIS 128

12.3.4 PRODUCT PORTFOLIO 128

12.3.5 RECENT DEVELOPMENTS 129

12.4 SIEMENS AG 130

12.4.1 COMPANY OVERVIEW 130

12.4.2 REVENUE ANALYSIS 130

12.4.3 COMPANY SHAREV ANALYSIS 131

12.4.4 PRODUCT PORTFOLIO 131

12.4.5 RECENT DEVELOPMENTS 133

12.5 BIO-RAD LABORATORIES, INC. 134

12.5.1 1.3.1COMPANY OVERVIEW 134

12.5.2 REVENUE ANALYSIS 134

12.5.3 COMPANY SHAREV ANALYSIS 135

12.5.4 PRODUCT PORTFOLIO 135

12.5.5 RECENT DEVELOPMENTS 137

12.6 BD 138

12.6.1 COMPANY OVERVIEW 138

12.6.2 REVENUE ANALYSIS 138

12.6.3 PRODUCT PORTFOLIO 139

12.6.4 RECENT DEVELOPMENTS 139

12.7 BECKMAN COULTER, INC. 140

12.7.1 COMPANY OVERVIEW 140

12.7.2 GEOGRAPHICPRESENCE 140

12.7.3 PODUCT PORTFOLIO 141

12.7.4 RECENET DEVELOPEMENTS 142

12.8 BIOMERIEUX SA 143

12.8.1 COMPANY OVERVIEW 143

12.8.2 REVENUE ANALYSIS 143

12.8.3 PRODUCT PORTFOLIO 144

12.8.4 RECENT DEVELOPMENT 145

12.9 CEPHEID (A SUBSIDIARY OF DANAHER CORPORATION) 146

12.9.1 COMPANY OVERVIEW 146

12.9.2 GEOGRAPHIC PRESENCE 146

12.9.3 PRODUCT PORTFOLIO 147

12.9.4 RECENT DEVELOPMENT 148

12.10 ENZO BIOCHEM INC. 149

12.10.1 COMPANY OVERVIEW 149

12.10.2 REVENUE ANALYSIS 149

12.10.3 PRODUCT PORTFOLIO 150

12.10.4 RECENT DEVELOPMENTS 151

12.11 GRIFOLS INTERNATIONAL, S.A. 152

12.11.1 COMPANY OVERVIEW 152

12.11.2 REVENUE ANALYSIS 152

12.11.3 PRODUCT PORTFOLIO 153

12.11.4 RECENT DEVELOPMENTS 154

12.12 HOLOGIC INC. 155

12.12.1 COMPANY OVERVIEW 155

12.12.2 REVENUE ANALYSIS 155

12.12.3 PRODUCT PORTFOLIO 156

12.12.4 RECENT DEVELOPMENTS 156

12.13 IMMUCOR, INC. 157

12.13.1 COMPANY OVERVIEW 157

12.13.2 GEOGRAPHIC PRESENCE: 157

12.13.3 PRODUCT PORTFOLIO 158

12.13.4 RECENT DEVELOPMENTS 159

12.14 MERIDIAN BIOSCIENCE, INC. 160

12.14.1 COMPANY OVERVIEW 160

12.14.2 REVENUE ANALYSIS 160

12.14.3 PRODUCT PORTFOLIO 161

12.14.4 RECENT DEVELOPMENTS 162

12.15 ORTHO CLINICAL DIAGNOSTICS 163

12.15.1 COMPANY OVERVIEW 163

12.15.2 GEOGRAPHIC PRESENCE 163

12.15.3 PRODUCT PORTFOLIO 164

12.15.4 RECENT DEVELOPMENTS 165

13 RELATED REPORTS 166

LIST OF FIGURES

FIGURE 1 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: SEGMENTATION 18

FIGURE 2 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: DATA TRIANGULATION 21

FIGURE 3 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: DROC ANALYSIS 22

FIGURE 4 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET:BOTTOM UP APPROACH 23

FIGURE 5 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET:TOP DOWN APPROACH 23

FIGURE 6 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: INTERVIEW DEMOGRAPHICS 24

FIGURE 7 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: DBMR MARKET POSITION GRID 25

FIGURE 8 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID 26

FIGURE 9 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID 27

FIGURE 10 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: THE MARKET CHALLENGE MATRIX 28

FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET 31

FIGURE 12 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: SEGMENTATION 40

FIGURE 13 RISE IN DEMAND OF BLOOD DONATIONS AND BLOOD DONORS AS WELL AS RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS EXPECTED TO DRIVE THE MARKET FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD 2018 TO 2025 41

FIGURE 14 REAGENTS & KITS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BLOOD SCREENING MARKET IN 2018 & 2025 42

FIGURE 15 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES, 2017 44

FIGURE 16 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: BY TECHNOLOGY, 2017 55

FIGURE 17 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: BY DISEASE TYPE, 2017 67

FIGURE 18 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: BY END USER, 2017 78

FIGURE 19 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SNAPSHOT (2017) 85

FIGURE 20 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET: BY COUNTRY (2017) 86

FIGURE 21 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025) 86

FIGURE 22 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET : BY COUNTRY (2017 & 2025) 87

FIGURE 23 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025) 87

FIGURE 24 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET: COMPANY SHARE 2017 (%) 103

LIST OF TABLES

TABLE 1 LIST OF PRICES FOR FEW DEVICES 36

TABLE 2 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025, (USD MILLION) 46

TABLE 3 MIDDLE EAST-AND AFRICA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 47

TABLE 4 MIDDLE EAST-AND AFRICA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 48

TABLE 5 MIDDLE EAST-AND AFRICA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 49

TABLE 6 MIDDLE EAST-AND AFRICA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 50

TABLE 7 MIDDLE EAST-AND AFRICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 52

TABLE 8 MIDDLE EAST-AND AFRICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 52

TABLE 9 MIDDLE EAST-AND AFRICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 53

TABLE 10 MIDDLE EAST-AND AFRICA SOFTWARE & SERVICES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 54

TABLE 11 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 57

TABLE 12 MIDDLE EAST-AND AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 58

TABLE 13 MIDDLE EAST-AND AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 59

TABLE 14 MIDDLE EAST-AND AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY REGION , 2016-2025 (USD MILLION) 59

TABLE 15 MIDDLE EAST-AND AFRICA RAPID TESTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 61

TABLE 16 MIDDLE EAST-AND AFRICA NEXT-GENERATION SEQUENCING (NGS) IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 62

TABLE 17 MIDDLE EAST-AND AFRICA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 63

TABLE 18 MIDDLE EAST-AND AFRICA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 63

TABLE 19 MIDDLE EAST-AND AFRICA WESTERN BLOT ASSAY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 65

TABLE 20 MIDDLE EAST-AND AFRICA OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 66

TABLE 21 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 69

TABLE 22 MIDDLE EAST-AND AFRICA ONCOLOGY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 70

TABLE 23 MIDDLE EAST-AND AFRICA DIABETES MELLITUS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 71

TABLE 24 MIDDLE EAST-AND AFRICA COLD & FLU IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 72

TABLE 25 MIDDLE EAST-AND AFRICA CHOLESTEROL IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 73

TABLE 26 MIDDLE EAST-AND AFRICA INFECTIOUS DISEASES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 74

TABLE 27 MIDDLE EAST-AND AFRICA RESPIRATORY DISEASESIN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 75

TABLE 28 MIDDLE EAST-AND AFRICA HIV/AIDS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 76

TABLE 29 MIDDLE EAST-AND AFRICA OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 77

TABLE 30 MIDDLE EAST-AND AFRICA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 80

TABLE 31 MIDDLE EAST-AND AFRICA DIAGNOSTIC CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 81

TABLE 32 MIDDLE EAST-AND AFRICA BLOOD BANK IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 82

TABLE 33 MIDDLE EAST-AND AFRICA HOSPITALS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 83

TABLE 34 MIDDLE EAST-AND AFRICA CLINICS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 84

TABLE 35 MIDDLE EAST-AND AFRICA AMBULATORY SURGICAL CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 85

TABLE 36 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY COUNTRY, 2016-2025 (USD MILLION) 89

TABLE 37 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 89

TABLE 38 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 90

TABLE 39 MIDDLE EAST & AFRICA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 90

TABLE 40 MIDDLE EAST & AFRICA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 91

TABLE 41 MIDDLE EAST & AFRICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 91

TABLE 42 MIDDLE EAST & AFRICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 92

TABLE 43 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 92

TABLE 44 MIDDLE EAST & AFRICA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 93

TABLE 45 MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 93

TABLE 46 MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 94

TABLE 47 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY DISEASES TYPE, 2016-2025 (USD MILLION) 94

TABLE 48 MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 95

TABLE 49 SOUTH AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 96

TABLE 50 SOUTH AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 96

TABLE 51 SOUTH AFRICA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 97

TABLE 52 SOUTH AFRICA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 98

TABLE 53 SOUTH AFRICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 98

TABLE 54 SOUTH AFRICA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 99

TABLE 55 SOUTH AFRICA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 99

TABLE 56 SOUTH AFRICA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 100

TABLE 57 SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 100

TABLE 58 SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 101

TABLE 59 SOUTH AFRICA BLOOD SCREENING MARKET, BY DISEASES TYPE, 2016-2025 (USD MILLION) 101

TABLE 60 SOUTH AFRICA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 102

TABLE 61 REST OF MIDDLE EAST & AFRICA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 103

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Enzo Biochem Inc.

Meridian Bioscience, Inc.

Bio-Rad Laboratories, Inc.

Thermo Fisher Scientific Inc.

BD

bioMerieux SA

Beckman Coulter, Inc.

Abbott

F. Hoffmann-La Roche Ltd

Cepheid

Grifols

Seimens AG

Ortho Clinical Diagnostics

Immucor, Inc.

Hologic Inc.

select a license
Single User License
USD 2500 INR 179800
Corporate User License
USD 3200 INR 230144

NEWSLETTER BY CATEGORY




Testimonials

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com